Cognition Therapeutics announced its Q3 2026 financial results, reporting a net loss of $4.1 million and $31.5 million in cash reserves. The company is progressing with FDA-aligned Phase 3 trial preparations for its dementia drug zervimesine (CT1812), targeting dementia with Lewy bodies (DLB). Top-line results from a Phase 2 Alzheimer’s study are expected in late 2027, which will guide further development. The company has sufficient funds to operate into Q4 2027 and continues to focus on neurodegenerative disease treatments.
Cognition Therapeutics' Q3 2026 financial results provide context for readers. For those following the Health sector, here is Pluang's market snapshot as of Nov 05, 2026 17:11 WIB: out of 150 priced US Health stocks, 82 rose and 59 fell. Notable movers include FLNA at USD 0.63 with a 9.21% increase and a typical hold time of 38 days, HUM at USD 386.84 down 7.33%, and NUWE at USD 5.60 up 6.26% with 92% sell order activity.
Perimeter Group Inc. announced a net income of $304.5 million for Q3 2026, reversing a prior year loss of $90.7 million, with net sales up 24% to $389.9 million. Growth was driven by a 14% increase in Fire Safety sales and an 84% surge in Specialty P...
ACM Research reported a 37% year-over-year revenue increase to $367.7 million in Q3 2026, driven by strong demand in electrochemical plating (ECP) and advanced packaging technologies. The company is expanding manufacturing capacity and global sales e...
Purple has renewed its partnership with Lucid Motors to continue providing WiFi services across Lucid's operations in Riyadh. This renewal ensures that both staff and visitors have secure and easy internet access, supporting Lucid's growing presence ...
Investec Bank Plc, acting as joint broker to SThree Plc, disclosed public dealings involving the purchase and sale of 118,333 ordinary shares each on November 4, 2026. The transactions were conducted within a price range of 295 to 304 per share. Ther...
Investec Bank plc, acting as joint broker for Gamma Communications Plc, disclosed transactions involving nearly one million ordinary shares on November 4, 2026. The bank purchased 999,970 shares at 1098 pence each and sold 962,128 shares at prices be...
